Prospective Evaluation of the Clinical Profile and Treatment Outcomes of Proximal Humerus Fractures. (SPHEER)
With an ageing population, fragility fractures secondary to osteoporosis are on a increasing trend. Proximal humerus fractures are common fractures which account for a significant proportion of these fragility fractures. They significantly affect patients function and independence particularly in the elderly.
Currently, treatment options range from conservative treatment with an arm sling to fixation either with plates or intramedullary devices to arthroplasty ranging from a hemiarthroplasty to the latest reverse shoulder arthroplasty. While is there has been a global trend towards surgical treatment for such fractures, there is significant controversy regarding the best treatment with many studies reporting disappointing functional outcomes including residual shoulder pain, limitation in shoulder motion and decreased quality of life regardless of treatment option selected.
In this day and age where healthcare cost is a big concern both at the individual patient level but at a government level as well, evaluating the cost effectiveness of treatment becomes essential as well. Currently in Singapore, there have been a significant trend of an increased use of surgical treatment of proximal humerus fractures however we have very little data in our local context not only to evaluate the clinical effectiveness but also the cost effectiveness of surgical treatment in comparison to conservative treatment.
The primary aim of the study is
To understand the epidemiology and prognostic factors for proximal humerus fractures
- Incidence
- Health service utilization
- clinical and functional outcomes
- To estimate the relative cost-effectiveness of surgical vs non-surgical treatment pathways for managing patients with proximal humerus fractures.
We hypothesize that surgical fixation of the proximal humerus is both clinically and cost effective
研究概览
地位
条件
研究类型
注册 (预期的)
联系人和位置
学习联系方式
- 姓名：Bryan Tan
- 电话号码：63577713
- 邮箱：bryan_tan@whc.sg
学习地点
-
-
-
Singapore、新加坡
- 招聘中
- Tan Tock Seng Hospital
-
接触：
- Bryan Tan
- 电话号码：63577713
- 邮箱：bryan_tan@whc.sg
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- Age 21 years old and above
- Radiologically confirmed proximal humerus fracture
- Within 3 weeks of their injury
Exclusion Criteria:
- Open fracture
- Mentally incompetent patients
- Co-morbidities precluding anaesthesia
- Severe soft tissue compromise
- Neurovascular compromise
- Pathological fracture other than osteoporosis
- Surgery delayed > 3 weeks
- Pregnancy
学习计划
研究是如何设计的？
设计细节
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Constant Shoulder Score - change over 6 weeks, 3, 6, 12 months
大体时间：Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months
|
To evaluate the clinical outcomes over time by comparing the change in constant shoulder score over a period of 1 year. The Constant Shoulder Score is used to assess the level of pain and the patient's ability to carry out normal daily activities. Constant score of the unaffected shoulder was also assessed at baseline to compare the function between the two shoulders. |
Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months
|
|
Oxford Shoulder Score - change over 6 weeks, 3, 6, 12 months
大体时间：Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months
|
A 12-item patient-report questionnaire developed to evaluate the outcome of shoulder surgery, excluding surgery for instability.
The OSS contains two subscales, pain and activities of daily living.
Each responses is of a 0-4 scoring format with a higher score representing better function.
Hence, the highest possible total score is 48 and a higher score represents a better outcome.
|
Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months
|
|
QuickDASH scoring - change over 6 weeks, 3, 6, 12 months
大体时间：Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months
|
This score is a subset of 11 items from the 30-item DASH and is a self-reported questionnaire in which the response options are presented as 5-point Likert scales.
At least 10 of the 11 items must be completed for a score to be calculated and the scores range from 0 (no disability) to 100 (most severe disability).
|
Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
EQ5D-5L - change over 6 weeks, 3, 6, 12 months
大体时间：Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months
|
EuroQol-5 Dimensions (EQ-5D) consists of 2 dimensions, the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS).
The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems.
The patient is asked to indicate his/her health state by selecting the most appropriate statement in each of the five dimensions.
This decision results in a 1-digit number that expresses the level selected for that dimension.
The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
The EQ VAS records the patient's self-rated health on a vertical visual analogue scale, where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'.
The VAS will be used as a quantitative measure of health outcome.
|
Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months
|
|
Costing questionnaire
大体时间：Assessed at 6 weeks, 3 months, 4.5 months, 6 months
|
Questionnaire measuring the direct and indirect costs
|
Assessed at 6 weeks, 3 months, 4.5 months, 6 months
|
合作者和调查者
调查人员
- 首席研究员：Bryan Tan、Tan Tock Seng Hospital
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.